Eisler Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Eisler Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-140,700	Closed	-$6.61M	–	953
2025 Q2	$6.61M	Buy	140,700 +111,900	+389%	+$4.98M	0.04%	335
2025 Q1	$1.27M	Buy	+28,800	New	+$1.33M	0.01%	679

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eisler Capital Management's SWTX Position: Q3 2025 in Review

Eisler Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 218 shares — an estimated $10.2K sold.

Eisler Capital Management first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $2.52M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Eisler Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Eisler Capital Management sold 218 SpringWorks Therapeutics shares in Q3 2025, an estimated $10.2K.
Eisler Capital Management first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Eisler Capital Management's SpringWorks Therapeutics position peaked at $2.52M in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.